Singapore General Hospital Pte Ltd

Consultant

Job Category:  Medical
Posting Date:  16 Jul 2025

Singapore General Hospital (SGH) is the first and largest acute tertiary care hospital in Singapore with multiple specialized services including haematology and transplant medicine.

 

The Central Tuberculosis Laboratory in SGH processes over 80,000 specimens a year. It is a spacious, purpose built BSL3/BSL2+ facility that accounts for 80% of the national TB workload. We are transitioning to a whole genome sequencing approach to TB diagnosis. In addition, the lab performs TB immunology, and identification and susceptibility testing of non-tuberculous Mycobacteria,

We seek a suitably qualified pathologist to join us and to undertake the following roles:  

  • Help lead a team of 30 staff and 2 consultants (including this post)
  • Undertake responsibilities in the areas of diagnostic mycobacteriology, education (including mentoring junior doctors), research and administration.

Requirements

  • Basic Medical Degree and FRCPath or FRCPA in Microbiology (or equivalent) are required.
  • At least 2 years of relevant experience in a TB Laboratory is preferred.
  • Experience with NGS/WGS would be an advantage.
  • Must be able to obtain specialist accreditation and registration in Singapore.

 

Interested candidates are encouraged to contact Dr Sng Li-Hwei (sng.li.hwei@singhealth.com.sg) or Dr Koh Tse Hsien (koh.tse.hsien@singhealth.com.sg) if they have any queries.

 

Application

To apply, please e-mail your application with a detailed curriculum vitae stating full personal particulars, educational and professional qualifications/registrations, internship postings, training and career history from the time of completion of internship, current employment details, publication and presentation details, research activities, present and expected salary, names and contacts of at least two professional referees and contact number to:  careers.medical@sgh.com.sg

 

(Only shortlisted applicants will be contacted for an interview.)

4071